Cholestano[6,7-c][1,2,5]thiadiazole(9CI)(64415-35-6)
- Name: Cholestano[6,7-c][1,2,5]thiadiazole(9CI)
- Synonyms:5H-Cyclopenta[1,2]phenanthro[9,10-c][1,2,5]thiadiazole,cholestano[6,7-c][1,2,5]thiadiazole deriv.; 5H-Cyclopenta[1,2]phenanthro[9,10-c][1,2,5]thiadiazole,10-(1,5-dimethylhexyl)-3b,4,6,7,7a,7b,8,9,9a,10,11,12,12a,12b-tetradecahydro-7a,9a-dimethyl-,[7aR-[7aa,7bb,9aa,10a(R*),13ab,13ba]]-; [7aR-[7aa,7bb,9aa,10a(R*),13ab,13ba]]-10-(1,5-Dimethylhexyl)3b,4,6,7,7a,7b,8,9,9a,10,11,12,12a,12b-tetradecahydro-7a,9a-dimethyl-5H-cyclopenta[1,2]phenanthro[9,10-c][1,2,5]thiadiazole
- Molecular Formula:C27H44 N2 S
- Molecular Weight:
- CAS Registry Number:64415-35-6
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 141434-36-8/gloeosteretriol
- 10022-25-0/1-Phenanthreneaceticacid, 7-(acetyloxy)tetradecahydro-2-(methoxycarbonyl)-2,4b-dimethyl-, [1S-(1a,2b,4ab,4ba,7a,8ab,10aa)]- (9CI)
- 132268-38-3/duramycin C
- 71173-01-8/3-[2-(dodecyloxy)ethoxy]propiononitrile
- 135383-82-3/Cercidin
- 38483-48-6/4,4-Methylenebischloroaniline
- 120890-70-2/propan-2-yl 2-chloro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidi n-1-yl]benzoate
- 90218-30-7/Benzenesulfonic acid, 2,3(or 3,4)-dimethyl-, mono-C10-14-branched alkyl derivs.
- 114763-53-0/Spiro[cyclodeca[b]furan-2(3H),2'(3'H)-furan],3a,4,4',5,5',8,9,11a-octahydro-3,5',5',6,10-pentamethyl-,(2R,3R,3aR,6E,10E,11aR)-rel- (9CI)
- 55720-12-2/N~2~-{(E)-[4-(diethylamino)phenyl]methylidene}-4-nitro-N~1~-phenylbenzene-1,2-diamine
- 79810-94-9/9-methylphenaleno[1,9-gh]quinoline
- 6489-87-8/2-[(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzoic acid
- 127039-29-6/(2E)-2-methyl-4-oxobut-2-en-1-yl nitrate
- 71256-88-7/4-(2-{[oxido(dithiophen-2-yl)-lambda~4~-sulfanylidene]amino}ethyl)morpholine
- 21917-20-4/1,2-cyclopentanedicarboxylate
- 15883-57-5/3-hydroxynaphthalene-2,7-disulphonic acid, sodium salt
- 560-88-3/BORNYL SALICYLATE
- 64415-35-6/Cholestano[6,7-c][1,2,5]thiadiazole(9CI)
- 26548-40-3/xylo-Hexose,2,6-dideoxy-3-C-methyl-3-O-methyl-
- 73231-78-4/Ethanaminium, 2-(2-(1-oxopropoxy)-1-oxopropoxy)-N,N,N-trimethyl-, 2,6- naphthalenedisulfonate (2:1)
- 84646-78-6/Pyrrolidine, 1-((3a,12b-dihydrodibenzo(b,f)-1,3-dioxolo(4,5-d)oxepin-2 -yl)methyl)-
- 102149-31-5/1H-Pyrazole-3-ethanamine,5-(2-furanyl)-4,5-dihydro-N,N-dimethyl-1-(4-methylphenyl)-, hydrochloride (1:1)
- 90320-43-7/Alstonia constricta, ext.
- 112667-34-2/Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI)
- 492-27-3/KYNURENIC ACID
- 80400-38-0/Iridium, eta5-pentamethylcyclopentadienyl-tetramethyl-
- 32410-98-3/N-(3-dimethylaminopropyl)-4-propan-2-yloxy-benzenesulfonamide
- 5902-33-0/methyl (5E)-5-[(3-chlorophenyl)methylidene]-2-methyl-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylate
- 174173-75-2/(2R,3R)-1,1-dioxido-2-(propan-2-yl)tetrahydrothiophen-3-yl {(2S,3R)-4-[(3aR,6S,7aS)-6-(tert-butylcarbamoyl)hexahydrothieno[3,2-c]pyridin-5(4H)-yl]-3-hydroxy-1-phenylbutan-2-yl}carbamate
- 13101-54-7/ERLOSE